Category ME L17 The Role of Regulatory T Cells in Experimental Autoimmune

Encephalomyelitis

Abstract Multiple sclerosis (MS) is an autoimmune disease of the central nervous

system affecting about 400,000 people in the US. MS is studied through a

mouse model, experimental autoimmune encephalomyelitis (EAE), which

causes symptoms similar to those of MS in humans, including paralysis.

However, some humans develop MS while others are healthy, without

disease. Likewise, some mouse strains are susceptible to EAE induction

while others are resistant to it. By understanding why certain mouse

strains can resist EAE development, the underlying mechanisms of

disease development can be deciphered. It is thought that one factor

influencing the response to EAE lies in the activities of a population of T

cells known as the regulatory T cells (Treg). It is proposed that resistant

mouse strains have a higher Treg activity and hence lower disease-

causing (effector) activity. SJL.B mice, when immunized with the

neuroantigen MOG, develop EAE. In contrast, no disease is induced when

the mice are immunized with another neuroantigen, MBP. Analysis with of

lymphoid cell populations with a powerful machine called flow cytometry,

it is possible to distinctly separate the disease-causing T cells (effector

cells) from the regulatory T cells (Treg cells). In this project, SJL.B mice

were immunized with the two neuro-antigens, MOG and MBP. T cells

were then sorted by flow cytometry into effector cells expressing high

levels of surface CD4 molecule (CD4hi) and Treg cells expressing CD4 and

CD25 surface molecules (CD4+CD25+). Comparing the frequencies of

Treg cells in MBP-immunized mice (resistant) versus Treg cells in MOG-

immunized mice (susceptible), results showed that EAE resistant mice did

have a higher frequency of Treg cells than did EAE susceptible mice.

These findings establish the significance of Treg cells in the modulation of

EAE and possibly MS. Targeting Treg cells in MS should allow the

development of new therapeutic approaches that can help control the

symptoms of MS.

Bibliography Shaw, M.K., Kim, C., Ho, K., Lisak, R.P., and Tse, H. Y. A combination of

adoptive transfer

and antigenic challenge induces consistent murine experimental

autoimmune encephalomyelitis

in C57BL/6 mice and other reputed resistant strains. J. Neuroimmunol.

39:139-149, 1992.

Segal, B. M. and Shevach, E. M. IL-12 unmasks latent autoimmune

disease in resistant

mice. J. Exp. Med. 184:771, 1996.
First Previous Next Last